Dosimetry of beryllium in cultured canine pulmonary alveolar macrophages

Abstract

This study was designed to determine the dosimetry within macrophages of beryllium compounds administered at sublethal doses. Information on the dosimetry of beryllium within macrophages is required to guide further efforts to isolate and characterize beryllium‐containing haptens. Inhalation of beryllium aerosols can cause chronic berylliosis, a progressive, granulomatous fibrosis of the lung. Studies in laboratory animals indicate that alveolar macrophages take up beryllium compounds and participate in a hypersensitivity immune response to beryllium‐containing antigen. Beagle dog macrophage cultures were incubated with ⁷BeSO₄ in solution or with suspensions of ⁷BeO particles that had been calcined at 500 or 1000°C. Beryllium‐7 was measured in fractions collected from cultures after successive centrifugation and filtration steps at 2, 6, 20, and 48 h after addition. An insignificant percentage of BeSO₄ was taken up by the cells and did not cause cytotoxicity. Maximum BeO uptake occurred within 6 h, was 60 ± 6% of added BeO, and was independent of BeO calcination temperature or specific surface area. Approximately 22% of 500°C BeO dissolved within 48 h after addition to cell culture, concurrent with 39% cell killing. Dissolved beryllium remained associated with cells until a cytotoxic concentration was reached (2.2 × 10⁻⁵ M, 15 nmol Be/10⁶ cells), when the beryllium was released into the medium. There was no significant dissolution of the 1000°C BeO within 48 h, and no significant cell killing. The results indicate that beryllium dissolved from phagocytized BeO was more cytotoxic than soluble beryllium added extracellularly. The data support an interactive mechanism in which phagocytized BeO particles were dissolved, and dissolved beryllium remained associated with the macrophage until a cytotoxic concentration accumulated, whereupon the beryllium was released to the medium and not appreciably taken up by viable cells.